Invion is a clinical-stage life-sciences company that is leading the global clinical development of the Photosoft™ technology for the treatment of cancers. Invion has been appointed exclusive distributor and licensee in Australia and New Zealand of Photosoft™. The appointment has been made by technology licensor, The Cho Group, a Hong Kong based group that has funded and successfully commercialised a number of unique and advanced technologies. Via an R&D services agreement between the two entities, the research and clinical trials of Photosoft™ are funded by The Cho Group. Invion has an alliance with leading Australian medical research institute, Hudson Institute of Medical Research, for the Photosoft™ research program.
View Top Employees from Invion LimitedWebsite | http://inviongroup.com |
Ticker | IVX |
Revenue | $694000 |
Employees | 11 (8 on RocketReach) |
Founded | 2012 |
Address | 100 Albert Rd, South Melbourne, Victoria 3205, AU |
Phone | +61 3 9692 7222 |
Fax | +61 7 3295 0599 |
Technologies |
JavaScript,
HTML,
PHP
+7 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Product Research, Data and Analytics, Design |
Competitors | Bellus Health, Catabasis Pharmaceuticals, Inc., Hua Medicine, Inflazyme Pharmaceuticals Ltd., Novan, Inc. |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular Invion Limited employee's phone or email?
The Invion Limited annual revenue was $694000 in 2024.
Warren Brown is the director of Invion Limited.
8 people are employed at Invion Limited.
Invion Limited is based in South Melbourne, Victoria.
The NAICS codes for Invion Limited are [5417, 541, 54].
The SIC codes for Invion Limited are [87, 873].